Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Abstract
Protein modification by the conjugation of ubiquitin moieties-ubiquitination-plays a major part in many biological processes, including cell cycle and apoptosis. The enzymes that mediate ubiquitin-conjugation have been well-studied, but much less is known about the ubiquitin-specific proteases that mediate de-ubiquitination of cellular substrates. To study this gene family, we designed a collection of RNA interference vectors to suppress 50 human de-ubiquitinating enzymes, and used these vectors to identify de-ubiquitinating enzymes in cancer-relevant pathways. We report here that inhibition of one of these enzymes, the familial cylindromatosis tumour suppressor gene (CYLD), having no known function, enhances activation of the transcription factor NF-κB. We show that CYLD binds to the NEMO (also known as IKKγ) component of the IκB kinase (IKK) complex, and appears to regulate its activity through de-ubiquitination of TRAF2, as TRAF2 ubiquitination can be modulated by CYLD. Inhibition of CYLD increases resistance to apoptosis, suggesting a mechanism through which loss of CYLD contributes to oncogenesis. We show that this effect can be relieved by aspirin derivatives that inhibit NF-κB activity, which suggests a therapeutic intervention strategy to restore growth control in patients suffering from familial cylindromatosis.
- Publication:
-
Nature
- Pub Date:
- August 2003
- DOI:
- 10.1038/nature01811
- Bibcode:
- 2003Natur.424..797B